Neuroactive properties of reproductive steroids

Headache

Volumn 47, Issue SUPPL. 2, 2007, Pages

  Herzog, Andrew G ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Headaches; Hormones; Migraine; Neurosteroids; Reproductive

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; BROMOCRIPTINE; CELL NUCLEUS RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GLUTAMIC ACID; GONADORELIN AGONIST; LEUPRORELIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; NEUROTRANSMITTER; OPIATE; PROGESTERONE; PROGESTERONE RECEPTOR; SEROTONIN; TAMOXIFEN; TESTOSTERONE;

BRAIN REGION; CELL ENERGY; DRUG MECHANISM; GABAERGIC SYSTEM; HORMONAL THERAPY; HUMAN; LIGAND BINDING; MENOPAUSE; MENSTRUAL MIGRAINE; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROANATOMY; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; OVARY CYCLE; PATHOPHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPRODUCTIVE HEALTH; REVIEW; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; STEROID BLOOD LEVEL; SYNAPTIC MEMBRANE;

ELECTROPHYSIOLOGY; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MIGRAINE DISORDERS; NERVOUS SYSTEM PHYSIOLOGY; NEURONS;

EID: 34548585429     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00817.x     Document Type: Review

References (78)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Results from the American Migraine Study II. Headache. 2001 41 : 646 657.
2. International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004 24 (suppl 1 1 151.
3. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972 22 : 355 365.
4. McEwen BS. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol. 2001 91 : 2785 2801.
5. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part I. Headache. 2006 46 : 3 23.
6. Gee KW, McCauley LD, Lan NC. A putative receptor for neurosteroids on the GABAA receptor complex: The pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol. 1995 9 : 207 227.
7. Paul SM, Purdy RH. Neuroactive steroids. Faseb J. 1992 6 : 2311 2322.
8. Pfaff D, Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J Comp Neurol. 1973 151 : 121 158.
9. MacLusky NJ, Clark AS, Naftolin F, Goldman-Rakic PS. Estrogen formation in the mammalian brain: Possible role of aromatase in sexual differentiation of the hippocampus and neocortex. Steroids. 1987 50 : 459 474.
10. Miranda RC, Sohrabji F, Toran-Allerand D. Interactions of estrogen with the neurotrophins and their receptors during neural development. Horm Behav. 1994 28 : 367 375.
11. Clark AS, MacLusky NJ, Goldman-Rakic PS. Androgen binding and metabolism in the cerebral cortex of the developing rhesus monkey. Endocrinology. 1988 123 : 932 940.
12. Kimura D. Sex differences in the brain. Sci Am. 1992 267 : 118 125.
13. Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol. 2002 450 : 256 271.
14. Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE, Hutchison JB. Aromatase expression by astrocytes after brain injury: Implications for local estrogen formation in brain repair. Neuroscience. 1999 89 : 567 578.
15. Allen AL, McCarson KE. Estrogen increases nociception-evoked brain-derived neurotrophic factor gene expression in the female rat. Neuroendocrinology. 2005 81 : 193 199.
16. Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993 336 : 293 306.
17. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 1994 14 : 7680 7687.
18. Gazzaley AH, Weiland NG, McEwen BS, Morrison JH. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci. 1996 16 : 6830 6838.
19. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J Neurosci. 1997 17 : 1848 1859.
20. Rudick CN, Woolley CS. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci. 2001 21 : 6532 6543.
21. Osterlund MK, Gustafsson JA, Keller E, Hurd YL. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab. 2000 85 : 3840 3846.
22. Ostlund H, Keller E, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci. 2003 1007 : 54 63.
23. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med. 2002 346 : 257 270.
24. Blurton-Jones M, Kuan PN, Tuszynski MH. Anatomical evidence for transsynaptic influences of estrogen on brain-derived neurotrophic factor expression. J Comp Neurol. 2004 468 : 347 360.
25. Osterlund MK, Witt MR, Gustafsson JA. Estrogen action in mood and neurodegenerative disorders: Estrogenic compounds with selective properties - the next generation of therapeutics. Endocrine. 2005 28 : 235 242.
26. Wallis CJ, Luttge WG. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat brain. J Neurochem. 1980 34 : 609 613.
27. Guerra-Araiza C, Cerbon MA, Morimoto S, Camacho-Arroyo I. Progesterone receptor isoforms expression pattern in the rat brain during the estrous cycle. Life Sci. 2000 66 : 1743 1752.
28. Fernandez-Ruiz JJ, de Miguel R, Hernandez ML, Ramos JA. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain. Pharmacol Biochem Behav. 1990 36 : 603 606.
29. Gomez-Mancilla B, Bedard PJ. Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys. Neurosci Lett. 1992 135 : 129 132.
30. Hernandez ML, Fernandez-Ruiz JJ, de Miguel R, Ramos JA. Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats. J Neural Transm Gen Sect. 1991 83 : 77 84.
31. Attali G, Weizman A, Gil-Ad I, Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 1997 756 : 153 159.
32. Becker JB, Rudick CN. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study. Pharmacol Biochem Behav. 1999 64 : 53 57.
33. Dluzen DE, Ramirez VD. Progesterone enhances L-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen- primed rats. Brain Res. 1989 494 : 122 128.
34. Kastrup Y, Hallbeck M, Amandusson A, Hirata S, Hermanson O, Blomqvist A. Progesterone receptor expression in the brainstem of the female rat. Neurosci Lett. 1999 275 : 85 88.
35. Smith SS. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res. 1989 503 : 354 357.
36. Wong M, Moss RL. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci. 1992 12 : 3217 3225.
37. Kawakami M, Terasawa E, Ibuki T. Changes in multiple unit activity of the brain during the estrous cycle. Neuroendocrinology. 1970 6 : 30 48.
38. Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit. Arch Neurol. 1966 15 : 521 532.
39. Toran-Allerand CD, Guan X, MacLusky NJ, et al. ER-X: A novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci. 2002 22 : 8391 8401.
40. Kuroki Y, Fukushima K, Kanda Y, Mizuno K, Watanabe Y. Putative membrane-bound estrogen receptors possibly stimulate mitogen-activated protein kinase in the rat hippocampus. Eur J Pharmacol. 2000 400 : 205 209.
41. Kelly MJ, Levin ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab. 2001 12 : 152 156.
42. Beyer C, Ivanova T, Karolczak M, Kuppers E. Cell type-specificity of nonclassical estrogen signaling in the developing midbrain. J Steroid Biochem Mol Biol. 2002 81 : 319 325.
43. Kokate TG, Svensson BE, Rogawski MA. Anticonvulsant activity of neurosteroids: Correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther. 1994 270 : 1223 1229.
44. Reddy DS, Castaneda DC, O'Malley BW, Rogawski MA. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther. 2004 310 : 230 239.
45. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998 392 : 926 930.
46. Frye CA. The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 1995 696 : 113 120.
47. Pouliot WA, Handa RJ, Beck SG. Androgen modulates N-methyl-D-aspartate- mediated depolarization in CA1 hippocampal pyramidal cells. Synapse. 1996 23 : 10 19.
48. Terasawa E, Timiras PS. Electrical activity during the estrous cycle of the rat: Cyclic changes in limbic structures. Endocrinology. 1968 83 : 207 216.
49. Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology. 1959 9 : 352 360.
50. Hom AC, Buterbaugh GG. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia. 1986 27 : 103 108.
51. Nicoletti F, Speciale C, Sortino MA, et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia. 1985 26 : 252 257.
52. Spiegel E, Wycis H. Anticonvulsant effects of steroids. J Lab Clin Med. 1945 30 : 947 953.
53. Woolley DE, Timiras PS. Estrous and circadian periodicity and electroshock convulsions in rats. Am J Physiol. 1962 202 : 379 382.
54. Smith SS, Waterhouse BD, Woodward DJ. Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res. 1988 475 : 272 282.
55. Landgren S, Backstrom T, Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J Neurol Sci. 1978 36 : 119 133.
56. Yang SH, Liu R, Perez EJ, et al. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A. 2004 101 : 4130 4135.
57. Green PS, Simpkins JW. Neuroprotective effects of estrogens: Potential mechanisms of action. Int J Dev Neurosci. 2000 18 : 347 358.
58. Mattson MP, Robinson N, Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport. 1997 8 : 3817 3821.
59. Phillis JW. Potentiation of the depression by adenosine of rat cerebral cortical neurones by progestational agents. Br J Pharmacol. 1986 89 : 693 702.
60. Nilsen J, Brinton RD. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport. 2002 13 : 825 830.
61. Kelly MJ, Loose MD, Ronnekleiv OK. Estrogen suppresses mu-opioid- and GABAB-mediated hyperpolarization of hypothalamic arcuate neurons. J Neurosci. 1992 12 : 2745 2750.
62. Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U, Phansuwan-Pujito P. 2002 Wolff Award. 5-HT2 A receptor activation and nitric oxide synthesis: A possible mechanism determining migraine attacks. Headache. 2002 42 : 566 574.
63. Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci. 1996 16 : 7021 7029.
64. Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology. 2004 29 : 2035 2045.
65. Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res. 1998 53 : 120 129.
66. Snyder SH. The opiate receptor and morphine-like peptides in the brain. Am J Psychiatry. 1978 135 : 645 652.
67. Fries DS. Opioid analgesics. In : Williams DA, ed. Foye's Principles of Medicinal Chemistry. Philadelphia, PA : Lippincott Williams & Wilkins 2002 : 453 479.
68. Facchinetti F, Martignoni E, Fioroni L, Sances G, Genazzani AR. Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. Cephalalgia. 1990 10 : 51 56.
69. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part 2. Headache. 2006 46 : 365 386.
70. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004 63 : 351 353.
71. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000 55 : 1517 1523.
72. Calhoun AH. A novel specific prophylaxis for menstrual-associated migraine. South Med J. 2004 97 : 819 822.
73. de Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed). 1986 293 : 1540.
74. Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: A double-blind trial of percutaneous estradiol. Gynecol Endocrinol. 1988 2 : 113 120.
75. Pradalier A, Vincent D, Beaulieu P, Baudesson G, Launay J-M. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In : Rose FC, ed. New Advances in Headache Research, 4th ed. London, England : Smith-Gordon 1994 : 129 132.
76. Lichten EM, Lichten JB, Whitty AJ, Pieper D. The use of leuprolide acetate in the diagnosis and treatment of menstrual migraine: The role of artificially induced menopause. Headache Q. 1995 6 : 313 317.
77. O'Dea JP, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology. 1990 40 : 1470 1471.
78. Herzog AG. Continuous bromocriptine therapy in menstrual migraine. Neurology. 1997 48 : 101 102.